SU

275.55

-0.22%↓

BAS

54.22

+0.06%↑

REP

21.14

+1.39%↑

AM

291.6

-1.75%↓

EXE.US

96.27

-0.17%↓

SU

275.55

-0.22%↓

BAS

54.22

+0.06%↑

REP

21.14

+1.39%↑

AM

291.6

-1.75%↓

EXE.US

96.27

-0.17%↓

SU

275.55

-0.22%↓

BAS

54.22

+0.06%↑

REP

21.14

+1.39%↑

AM

291.6

-1.75%↓

EXE.US

96.27

-0.17%↓

SU

275.55

-0.22%↓

BAS

54.22

+0.06%↑

REP

21.14

+1.39%↑

AM

291.6

-1.75%↓

EXE.US

96.27

-0.17%↓

SU

275.55

-0.22%↓

BAS

54.22

+0.06%↑

REP

21.14

+1.39%↑

AM

291.6

-1.75%↓

EXE.US

96.27

-0.17%↓

Search

Eurofins Scientific SE

Fechado

61.26 -2.11

Visão Geral

Variação de preço das ações

24h

Atual

Mín

61.16

Máximo

63.28

Indicadores-chave

By Trading Economics

Rendimento

105M

228M

Vendas

1.9B

3.7B

P/E

Médio do Setor

27.271

77.607

EPS

1.221

Rendimento de Dividendos

1.03

Margem de lucro

6.2

Funcionários

65,694

EBITDA

285M

693M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+25.16% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

1.03%

3.49%

Próximos Ganhos

22 de jul. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-320M

12B

Abertura anterior

63.37

Fecho anterior

61.26

Pontuação Técnica

By Trading Central

Confiança

Weak Bearish Evidence

Eurofins Scientific SE Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

26 de abr. de 2026, 21:14 UTC

Notícias Principais

Week Ahead for FX, Bonds: Major Central Bank Meetings Due as Middle East Conflict Continues

26 de abr. de 2026, 21:14 UTC

Notícias Principais

Week Ahead for FX, Bonds: Major Central Bank -2-

24 de abr. de 2026, 19:19 UTC

Aquisições, Fusões, Aquisições de Empresas

Intertek Group Rejects EQT's Revised Offer

26 de abr. de 2026, 23:48 UTC

Conversa de Mercado

Nikkei May Rise After U.S. Tech Gains -- Market Talk

26 de abr. de 2026, 23:44 UTC

Ganhos

Sinopharm 1Q Net CNY1.41B Vs. Net CNY1.46B >1099.HK

26 de abr. de 2026, 23:44 UTC

Ganhos

Sinopharm 1Q Rev CNY140.77B Vs. CNY141.66B >1099.HK

26 de abr. de 2026, 23:36 UTC

Conversa de Mercado
Notícias Principais

Gold Falls Amid Dollar's Strength -- Market Talk

26 de abr. de 2026, 23:33 UTC

Conversa de Mercado
Notícias Principais

Oil Rises Amid Ongoing Middle East Tensions -- Market Talk

26 de abr. de 2026, 05:12 UTC

Ganhos

Citic Securities: Results Also Aided by Higher Income from Brokerage, Income Banking Business >6030.HK

26 de abr. de 2026, 05:12 UTC

Ganhos

Citic Securities: Increase in Net Interest Income Supported Results >6030.HK

26 de abr. de 2026, 05:12 UTC

Ganhos

Citic Securities 1Q Rev CNY23.16B Vs. CNY16.43B >6030.HK

26 de abr. de 2026, 05:12 UTC

Ganhos

Citic Securities 1Q Net CNY10.22B Vs. Net CNY6.61B >6030.HK

24 de abr. de 2026, 23:37 UTC

Aquisições, Fusões, Aquisições de Empresas

Scoring the Cook Era -- Barrons.com

24 de abr. de 2026, 20:51 UTC

Aquisições, Fusões, Aquisições de Empresas

Organon Stock Surges 31% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

24 de abr. de 2026, 20:50 UTC

Conversa de Mercado
Notícias Principais

Financial Services Roundup: Market Talk

24 de abr. de 2026, 20:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

24 de abr. de 2026, 20:39 UTC

Aquisições, Fusões, Aquisições de Empresas

Organon Stock Surges 31% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

24 de abr. de 2026, 20:09 UTC

Ganhos

Tesla Stock Rises After Upgrade But Heads for Weekly Loss. Why AI Is Key. -- Barrons.com

24 de abr. de 2026, 19:48 UTC

Conversa de Mercado
Notícias Principais

Oil Posts Weekly Gains on Continued Hormuz Closure -- Market Talk

24 de abr. de 2026, 19:25 UTC

Aquisições, Fusões, Aquisições de Empresas

Organon Stock Surges 30% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

24 de abr. de 2026, 19:25 UTC

Aquisições, Fusões, Aquisições de Empresas

QXO Continues to Tumble Following TopBuild Deal -- Barrons.com

24 de abr. de 2026, 19:22 UTC

Ganhos

Dell AI Infrastructure Deal Shows That Hyperscalers Aren't the Only Players. Plus, Adobe and 4 More Stocks. -- Barrons.com

24 de abr. de 2026, 19:06 UTC

Ganhos

Earnings Season Was Supposed to Drive the Stock Market. Why It Hasn't. -- Barrons.com

24 de abr. de 2026, 19:05 UTC

Conversa de Mercado

U.S. Natural Gas Falls As Market Frets Over Storage -- Market Talk

24 de abr. de 2026, 18:30 UTC

Aquisições, Fusões, Aquisições de Empresas

Intertek: EQT's GBP54/Shr Offer 'Fundamentally Undervalues Intertek and Its Future Prospects'

24 de abr. de 2026, 18:28 UTC

Aquisições, Fusões, Aquisições de Empresas

Intertek Rejects Revised EQT Offer

24 de abr. de 2026, 18:12 UTC

Conversa de Mercado

Precious Metals Rise, But Remain Negative for the Week -- Market Talk

24 de abr. de 2026, 18:06 UTC

Conversa de Mercado

Oil Futures Extend Losses on Plans for U.S.-Iran Talks -- Market Talk

24 de abr. de 2026, 17:42 UTC

Ganhos

Even Nvidia Stock Is Getting an Intel Boost. It's on Pace for a Record High. -- Barrons.com

24 de abr. de 2026, 17:28 UTC

Ganhos

Palantir Stock Is Down 20% in 2026. Why This Analyst Says It's a Buy. -- Barrons.com

Comparação entre Pares

Variação de preço

Eurofins Scientific SE Previsão

Preço-alvo

By TipRanks

25.16% parte superior

Previsão para 12 meses

Média 77.35 EUR  25.16%

Máximo 81 EUR

Mínimo 73.7 EUR

Com base em 2 analistas de Wall Street que oferecem metas de preço de 12 meses para Eurofins Scientific SE - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

2 ratings

1

Comprar

1

Manter

0

Vender

Pontuação Técnica

By Trading Central

54.22 / 56.82Suporte e Resistência

Curto Prazo

Weak Bearish Evidence

Médio Prazo

Strong Bullish Evidence

Longo Prazo

Bullish Evidence

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Eurofins Scientific SE

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of various analytical methods and tests to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products. It provides services such as agroscience, including biological assessment, consumer and human, and environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, such as product inspection, auditing, certification, training and consultation of food, consumer products, healthcare and cosmetics, and food supplements; biopharma, and clinical diagnostics. In addition, the company offers consumer product testing, which include sustainability, expert services and regulatory, consumer research and sensory evaluation, audits, testing, certifications and approvals, inspections, and training courses for various industries; cosmetics and personal care; environment testing, including water, air, soil, waste, and other products testing; and food and feed testing that include allergen, GMO, grain, meat, nano material, pesticides, and residual DNA testing. Further, it offers audit and certification, training and consulting; food irradiation and labelling, heavy metals, carbohydrates, radioactivity, nutritional analysis, microbiolody, and testing for persistent organic pollutants, veterinary drug residue, dioxins and organic contaminants, pesticides, mycotoxins, and vitamins, as well as analyses for genetic modifications. Additionally, the company provides forensic, genomic, maritime, materials and engineering, REACH, and other services. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg.
help-icon Live chat